SEC Form 4 · accession 0001493152-17-011992
Q/C TECHNOLOGIES, INC. · QCLS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
John J Gormally
Officer — Chief Executive Officer · Director
Period of report
Oct 17, 2017
Accepted (ET)
Oct 24, 2017 · 4:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001321834
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 17, 2017 | G | 150,000 | $0.88 | A | 180,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On October 17, 2017, the Board of Directors of Akers Biosciences, Inc. approved the issuance of 150,000 restricted shares of common stock to the reporting person pursuant to the Akers Biosciences, Inc. 2017 Equity Incentive Plan.